Baseline characteristics in the Myopia Progression Study, a clinical trial of bifocals to slow myopia progression.
BACKGROUND: Retrospective studies have indicated that myopic children with nearpoint esophoria experienced slower myopia progression if they wore bifocal glasses rather than single-vision glasses. A small, 18-month clinical trial also supported that finding, but the results were not statistically significant. The Myopia Progression Study was funded by the National Eye Institute to test more rigorously the efficacy of bifocals, compared with single-vision glasses, in slowing myopia progression in children with nearpoint esophoria. A secondary objective of the study was to identify other variables that might influence the rate of myopia progression. This report describes the design and methods of the Myopia Progression Study and the baseline characteristics of the subjects. METHODS: A 3-year, randomized clinical trial was initiated. Subjects were children between 6 and 12 years of age who were myopic (at least -0.50 D in each eye) and who demonstrated nearpoint esophoria by the von Graefe technique. RESULTS: Eighty-two children were enrolled. After blocking by gender and clinical site (two sites), subjects were randomly assigned to one of the two treatments: correction with single-vision spectacle lenses or correction with bifocal lenses having a +1.50 D add in a flattop segment. The average degree of myopia at baseline was -2.31 D (SD = 1.31 D). CONCLUSION: This clinical trial can be expected to determine the effectiveness of bifocal glasses in slowing the progression of myopia in children with nearpoint esophoria.[1]References
- Baseline characteristics in the Myopia Progression Study, a clinical trial of bifocals to slow myopia progression. Fulk, G.W., Cyert, L.A., Parker, D.E. Optometry and vision science : official publication of the American Academy of Optometry. (1998) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
